Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader ...

(Reuters) -Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries from the drugmaker's human ...

February 20, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Merck & Co., Inc. (NYSE: MRK) securities between February 3, 2022 and February 3, 2025, ...

Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries from the drugmaker's human papillomavirus vaccine in a case with ties to U.S. Department of Health and Human ...

Deutsche Bank analyst James Shin downgraded Merck (MRK) to Hold from Buy with a $105 price target See what stocks are receiving strong buy ratings from top-rated analysts. Filter, analyze ...

Kennedy Jr.’s confirmation as President Trump’s health secretary. Mark Lanier, a lawyer for the plaintiff in the case, said Tuesday that Merck agreed to halting the trial in state court in Los ...

FRANKFURT, Feb 18 (Reuters) - Germany's Merck KGaA (MRCG.DE), opens new tab said on Tuesday its lab equipment division and its pharmaceuticals division would be under new leadership from June but ...

“The consumer is becoming CEO of his or her own health,” argues Marvin Amberg, founder of Berlin-based naturalX Health Ventures, which will today announce it has raised a €100 million fund ...

Darmstadt-based Merck’s strategic tie-up with the China-based multinational tech company will initially focus on increasing public disease awareness and providing more accessible health services ...

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other cheap high dividend stocks. According to Deutsche Bank Wealth Management, the global ...